BIRK 6-K
Birkenstock Holding plc (BIRK)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the Month of August
Commission file number:
(Translation of registrant's name into English)
1-2 Berkeley Square
London W1J 6EA
United Kingdom
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Table of Contents
PART I FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
Birkenstock Holding plc
Unaudited Interim Condensed Consolidated Financial Statements
as of June 30, 2024 and for the three and nine months ended June 30, 2024 and 2023
1
Unaudited Interim Condensed Consolidated Statements of Financial Position
(In thousands of Euros) |
Notes |
|
June 30, 2024 |
|
|
September 30, 2023 |
|
||
Assets |
|
|
|
|
|
|
|
||
Non-current assets |
|
|
|
|
|
|
|
||
Goodwill |
|
|
|
|
|
|
|
||
Intangible assets (other than goodwill) |
|
|
|
|
|
|
|
||
Property, plant and equipment |
6 |
|
|
|
|
|
|
||
Right-of-use assets |
7 |
|
|
|
|
|
|
||
Other assets |
|
|
|
|
|
|
|
||
Total non-current assets |
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
Current assets |
|
|
|
|
|
|
|
||
Inventories |
8 |
|
|
|
|
|
|
||
Right to return assets |
|
|
|
|
|
|
|
||
Trade and other receivables |
|
|
|
|
|
|
|
||
Current tax assets |
|
|
|
|
|
|
|
||
Other current assets |
|
|
|
|
|
|
|
||
Cash and cash equivalents |
|
|
|
|
|
|
|
||
Total current assets |
|
|
|
|
|
|
|
||
Total assets |
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
Shareholders' equity and liabilities |
|
|
|
|
|
|
|
||
Shareholders' equity |
|
|
|
|
|
|
|
||
Ordinary shares |
9 |
|
|
|
|
|
|
||
Share premium |
9 |
|
|
|
|
|
|
||
Treasury shares |
9 |
|
|
( |
) |
|
|
— |
|
Other capital reserve |
9 |
|
|
|
|
|
|
||
Retained earnings |
9 |
|
|
|
|
|
|
||
Accumulated other comprehensive income |
9 |
|
|
|
|
|
|
||
Total shareholders' equity |
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
Non-current liabilities |
|
|
|
|
|
|
|
||
Loans and borrowings |
11 |
|
|
|
|
|
|
||
Tax receivable agreement liability |
12 |
|
|
|
|
|
— |
|
|
Lease liabilities |
|
|
|
|
|
|
|
||
Provisions for employee benefits |
|
|
|
|
|
|
|
||
Other provisions |
|
|
|
|
|
|
|
||
Deferred tax liabilities |
|
|
|
|
|
|
|
||
Deferred income |
13 |
|
|
|
|
|
|
||
Other liabilities |
|
|
|
|
|
|
|
||
Total non-current liabilities |
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
Current liabilities |
|
|
|
|
|
|
|
||
Loans and borrowings |
11 |
|
|
|
|
|
|
||
Lease liabilities |
|
|
|
|
|
|
|
||
Trade and other payables |
|
|
|
|
|
|
|
||
Accrued liabilities |
|
|
|
|
|
|
|
||
Other financial liabilities |
|
|
|
|
|
|
|
||
Other provisions |
|
|
|
|
|
|
|
||
Contract liabilities |
|
|
|
|
|
|
|
||
Current tax liabilities |
|
|
|
|
|
|
|
||
Deferred income |
13 |
|
|
|
|
|
|
||
Other current liabilities |
|
|
|
|
|
|
|
||
Total current liabilities |
|
|
|
|
|
|
|
||
Total liabilities |
|
|
|
|
|
|
|
||
Total shareholders' equity and liabilities |
|
|
|
|
|
|
|
||
2
Unaudited Interim Condensed Consolidated Statements of Comprehensive Income (Loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
Three months ended |
|
|
Nine months ended |
|
||||||||||
(In thousands of Euros, except share and per share information) |
Notes |
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Revenue |
14 |
|
|
|
|
|
|
|
|
|
|
|
||||
Cost of sales |
15 |
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Gross profit |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Operating expenses |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|||
Selling and distribution expenses |
15 |
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
General administration expenses |
15 |
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Foreign exchange loss |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Other income (expenses), net |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|||
Profit from operations |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Finance cost, net |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Profit before tax |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Income tax expense |
16 |
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Net profit |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Items that may be reclassified to profit (loss) in subsequent periods (net of tax): |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Cumulative translation adjustment gain (loss) |
|
|
|
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
Net position of fair value changes of the cash flow hedge |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Other comprehensive income (loss) |
|
|
|
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
Total comprehensive income (loss) |
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Earnings per share |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic |
17 |
|
|
|
|
|
|
|
|
|
|
|
||||
Diluted |
17 |
|
|
|
|
|
|
|
|
|
|
|
||||
3
|
|
Ordinary shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive income (loss) |
|
|
|
|
|||||||||||||||
(In thousands of Euros, except share and per share information) |
Notes |
Number of shares |
|
|
Amount |
|
Share Premium |
|
|
Treasury Shares |
|
|
Other Capital Reserve |
|
|
Retained Earnings |
|
|
Cumulative translation adjustment |
|
|
Cash flow hedge reserve |
|
|
Shareholders' equity |
|
|||||||||
Balance at September 30, 2022 |
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
||||||
Net profit |
|
|
— |
|
|
|
— |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
||
Other comprehensive income (loss) |
|
|
— |
|
|
|
— |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
|
|
|
( |
) |
|
Total comprehensive income (loss) |
|
|
— |
|
|
|
— |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
( |
) |
||
Equity-settled share-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Balance at June 30, 2023 |
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Balance at September 30, 2023 |
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|||||||
Net profit |
|
|
— |
|
|
|
— |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
||
Other comprehensive income (loss) |
|
|
— |
|
|
|
— |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
|
|
|
( |
) |
|
Total comprehensive income (loss) |
|
|
— |
|
|
|
— |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|||
Equity-settled share-based compensation expense |
18, 20 |
|
— |
|
|
|
— |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
||
Conversion to no par value ordinary shares |
9 |
|
— |
|
|
|
( |
) |
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Shares re-purchased in consideration of Tax Receivable Agreement |
12 |
|
( |
) |
|
|
— |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Issuance of share capital, net (of total transaction costs € |
9 |
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|||
Issuance of ordinary shares related to vesting of RSUs |
20 |
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
— |
|
|||||||
Balance at June 30, 2024 |
|
|
|
|
|
- |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
|
||||||
4
Unaudited Interim Condensed Consolidated Statements of Cash Flows
|
|
|
|
|
|
|||||
|
|
|
|
Nine months ended June 30, |
|
|||||
(In thousands of Euros) |
|
|
|
2024 |
|
|
2023 |
|
||
Cash flows from operating activities |
|
|
|
|
|
|
|
|
||
Net profit |
|
|
|
|
|
|
|
|
||
Adjustments to reconcile net profit to net cash flows from operating activities: |
|
|
|
|
|
|
|
|
||
Depreciation and amortization |
|
|
|
|
|
|
|
|
||
Change in expected credit loss |
|
|
|
|
( |
) |
|
|
|
|
Finance cost, net |
|
|
|
|
|
|
|
|
||
Net exchange differences |
|
|
|
|
|
|
|
|
||
Non-cash operating items |
|
|
|
|
|
|
|
|
||
Income tax expense |
|
|
|
|
|
|
|
|
||
Income tax paid |
|
|
|
|
( |
) |
|
|
( |
) |
MIP personal income tax paid |
|
|
|
|
( |
) |
|
|
|
|
Changes in working capital: |
|
|
|
|
|
|
|
|
||
- Inventories |
|
|
|
|
( |
) |
|
|
( |
) |
- Right to return assets |
|
|
|
|
( |
) |
|
|
( |
) |
- Trade and other receivables |
|
|
|
|
( |
) |
|
|
( |
) |
- Trade and other payables |
|
|
|
|
|
|
|
|
||
- Accrued liabilities |
|
|
|
|
( |
) |
|
|
|
|
- Other current financial liabilities |
|
|
|
|
|
|
|
( |
) |
|
- Other current provision |
|
|
|
|
( |
) |
|
|
( |
) |
- Contract liabilities |
|
|
|
|
|
|
|
|
||
- Prepayments |
|
|
|
|
( |
) |
|
|
|
|
- Other |
|
|
|
|
|
|
|
|
||
Net cash flows provided by operating activities |
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
||
Cash flows from investing activities |
|
|
|
|
|
|
|
|
||
Interest received net of taxes withheld |
|
|
|
|
|
|
|
|
||
Purchases of property, plant and equipment |
|
|
|
|
( |
) |
|
|
( |
) |
Proceeds from sale of property, plant and equipment |
|
|
|
|
|
|
|
|
||
Purchases of intangible assets |
|
|
|
|
( |
) |
|
|
( |
) |
Proceeds from sale of intangible assets |
|
|
|
|
|
|
|
|
||
Receipt of government grant |
|
|
|
|
|
|
|
|
||
Net cash flows used in investing activities |
|
|
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
||
Cash flows from financing activities |
|
|
|
|
|
|
|
|
||
IPO Proceeds, net (of underwriting commission fees € |
|
|
|
|
|
|
|
|
||
Repayment of loans and borrowings |
|
|
|
|
( |
) |
|
|
( |
) |
Interest paid |
|
|
|
|
( |
) |
|
|
( |
) |
Payments of lease liabilities |
|
|
|
|
( |
) |
|
|
( |
) |
Interest portion of lease liabilities |
|
|
|
|
( |
) |
|
|
( |
) |
Net cash flows used in financing activities |
|
|
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
||
Net increase (decrease) in cash and cash equivalents |
|
|
|
|
|
|
|
( |
) |
|
Cash and cash equivalents at beginning of period |
|
|
|
|
|
|
|
|
||
Net foreign exchange difference |
|
|
|
|
( |
) |
|
|
( |
) |
Cash and cash equivalents at end of period |
|
|
|
|
|
|
|
|
||
5
Notes to THE Unaudited INTERIM CONDENSED Consolidated Financial Statements
1. GENERAL INFORMATION
Organization and principal activities
Birkenstock Holding plc (together with its subsidiaries referred to herein as the “Company” or “Birkenstock”) was formed under the name of BK LC Lux Finco 2 S.à r.l. on February 19, 2021, as a limited liability company organized under Luxembourg law, with its business address at 40 Avenue Monterey, Luxembourg. On October 4, 2023, the Company converted to a public limited company organized under Jersey law and changed its name to Birkenstock Holding plc. The Company’s current business address is 1-2 Berkeley Square, London W1J 6EA, United Kingdom. The Company is registered at the Jersey Financial Services Commission under number 148522.
The Company’s controlling shareholder is BK LC Lux MidCo S.à r.l. (“MidCo”) and the Company’s ultimate controlling shareholder is LC9 Caledonia AIV GP, LLP (“L Catterton”).
The Company manufactures and sells footbed-based products, including sandals and closed-toe silhouettes, and other products, such as skincare and accessories, for everyday leisure, and work. The Company operates in four operating segments based on its regional hubs: (1) Americas, (2) Europe, (3) Asia, the South Pacific, and Australia (“ASPA”), and (4) the Middle East, Africa, and India (“MEAI”) (see Note 5 – Segment information for further details). All segments have the same operations. The Company sells its products through two main channels: business-to-business (“B2B”) (comprising sales made to established third-party store networks), and direct-to-consumer (“DTC”) (comprising sales made on globally owned online stores via the Birkenstock.com domain and sales made in Birkenstock retail stores).
Seasonality
Revenue of our products are affected by a seasonal pattern that is driven in large part by the weather given the nature of our product mix. The seasonal nature of our business is similar across geographies and sales channels with B2B seeing an increase in revenue in the spring months, while revenue in the DTC channel increasing in the summer. Between October and March, we manufacture our products for the B2B channel, and during the first few months of the calendar year, we rely on our built-up inventory for our revenue to B2B partners. Starting in April and during the warmer months of the year, demand for our products from the DTC channel increases. While these consumer buying patterns lead to a natural seasonality in revenue, unseasonable weather could significantly affect revenue and profitability. Our geographical breadth, customer diversity and our strategic focus on expanding certain product categories and entering new territory helps to mitigate part of the effect of seasonality on results of operations.
2. BASIS OF PRESENTATION
Basis of preparation and consolidation
These interim condensed consolidated financial statements were authorized for issuance by the Company’s Audit Committee on August 29, 2024.
These interim condensed consolidated financial statements as of June 30, 2024 and for the three and nine months ended June 30, 2024 and 2023 have been prepared in accordance with International Accounting Standard ("IAS") 34 "Interim Financial Reporting", as issued by the International Accounting Standard Board (“IASB”). These interim condensed consolidated financial statements should be read in conjunction with the annual consolidated financial statements for the fiscal year ended September 30, 2023, which have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the IASB, taking into account the recommendations of the International Financial Reporting Standards Interpretations Committee (“IFRIC”).
These interim condensed consolidated financial statements have been prepared on a historical cost basis except for derivative financial instruments and the initial recognition of assets acquired and liabilities assumed in a business combination which are recorded at fair value.
The interim condensed consolidated financial statements comprise the financial statements of Birkenstock Holding plc and its subsidiaries. All intercompany transactions and balances have been eliminated.
All amounts have been rounded to the nearest thousand, unless otherwise indicated.
6
The fiscal year of the Company ends on September 30.
The companies consolidated in these interim condensed consolidated financial statements are disclosed in the notes to the annual consolidated financial statements for the fiscal year ended September 30, 2023.
Functional and presentation currency
3. SIGNIFICANT ACCOUNTING POLICIES
The accounting policies applied in these interim condensed consolidated financial statements are predominantly the same as those applied by Birkenstock in its consolidated financial statements for the fiscal year ended September 30, 2023.
The Company has not early adopted any standard, interpretation or amendment that has been issued but is not yet effective.
Change in accounting estimate
The Company distributes its footwear produced predominantly in Germany and Portugal to its own (distribution) legal entities around the world with an intercompany margin, which is eliminated on consolidation. Commencing with the fiscal year ending September 30, 2024, the Company has refined its calculation of this intercompany profit elimination ("ICP") to more precisely reflect the turnover of inventory. This more accurate computation also has a foreign currency impact on the Cost of Sales converted to the reporting currency Euro. If the prior ICP model computation had still been applied in this fiscal year, the Company would have recorded an incremental expense (Cost of Sales) of €
New and amended standards and interpretations adopted by the Company
The following amended standards became effective for the Company’s fiscal year beginning on October 1, 2023, but did not have a material impact on the unaudited interim condensed consolidated financial statements of the Company:
New and amended standards and interpretations issued but not yet effective
The following standard amendments will be effective for the Company's fiscal year beginning October 1, 2024, or thereafter, and are not expected to have a material impact on the unaudited interim condensed consolidated financial statements of the Company:
7
IFRS 18 - Presentation and Disclosure in Financial Statements will be effective for periods beginning on or after January 1, 2027 and the Company is currently assessing the potential impact of the new standard.
4. SIGNIFICANT ACCOUNTING ESTIMATES, ASSUMPTIONS AND JUDGMENTS
The preparation of Birkenstock’s consolidated financial statements in accordance with IFRS requires management to make estimates and judgments in applying the Company’s accounting policies that affect the reported amounts and disclosures made in the interim condensed consolidated financial statements and accompanying notes. Uncertainty about these assumptions and estimates could result in outcomes that require a material adjustment to the carrying amount of assets or liabilities affected in future periods. The estimates and underlying assumptions are subject to continuous review.
During the three and nine months ended June 30, 2024, the Company made significant estimates and assumptions to determine the Company's contractual obligations and its fair value under the Tax Receivable Agreement entered into, between the Company and MidCo, on October 10, 2023 (the "Tax Receivable Agreement" or "TRA"). These significant estimates and assumptions include forecasting taxable income and estimating the timing of when certain taxable benefits will be realized in future years. For details on the TRA please refer to Note 12 - Tax Receivable Agreement.
In preparing the interim condensed consolidated financial statements, no significant changes in accounting estimates, assumptions and judgments have occurred compared to the significant accounting judgments, estimates and assumptions discussed in the consolidated financial statements as of and for the fiscal year ended September 30, 2023, except for the change in estimate described above.
5. SEGMENT INFORMATION
The Company’s operating segments are reported in a manner consistent with the internal reporting provided to and regularly reviewed by the chief operating decision maker (“CODM”), the Chief Executive Officer (“CEO”), and are aligned to the
The adjustments to EBITDA relate to realized and unrealized foreign exchange gain / (loss), initial public offering ("IPO")-related costs, share-based compensation and other adjustments relating to non-recurring items.
As of March 31, 2023, the Company changed its internal reporting to the CODM to report results prepared in accordance with IFRS.
Assets and liabilities are neither reported nor reviewed by the CODM at the operating segment level.
8
|
|
Three months ended June 30, 2024 |
|
||||||||||||||||||||||
(In thousands of Euros) |
|
Americas |
|
|
Europe |
|
|
APMA |
|
|
|
Total Reportable Segments |
|
|
Corporate / Other |
|
|
Total |
|
||||||
Revenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Adjusted EBITDA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|||||
Realized and unrealized FX gains / losses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|||||
Secondary offering related costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|||||
EBITDA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|||||
Finance cost, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|||||
Profit before tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Three months ended June 30, 2023 |
|
||||||||||||||||||||||
(In thousands of Euros) |
|
Americas |
|
|
Europe |
|
|
APMA |
|
|
|
Total Reportable Segments |
|
|
Corporate / Other |
|
|
Total |
|
||||||
Revenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Adjusted EBITDA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|||||
IPO-related costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|||||
Realized and unrealized FX gains / losses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|||||
Share-based compensation expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|||||
Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
EBITDA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|||||
Finance cost, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|||||
Profit before tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Nine months ended June 30, 2024 |
|||||||||||
(In thousands of Euros) |
|
Americas |
|
Europe |
|
APMA |
|
|
Total Reportable Segments |
|
Corporate / Other |
|
Total |
Revenue |
|
|
|
|
|
|
|
||||||
Adjusted EBITDA |
|
|
|
|
|
|
( |
|
|||||
IPO-related costs |
|
|
|
|
|
|
|
|
|
|
|
|
( |
Realized and unrealized FX gains / losses |
|
|
|
|
|
|
|
|
|
|
|
|
( |
Share-based compensation expenses |
|
|
|
|
|
|
|
|
|
|
|
|
( |
Secondary offering related costs |
|
|
|
|
|
|
|
|
|
|
|
|
( |
EBITDA |
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
|
|
( |
Finance cost, net |
|
|
|
|
|
|
|
|
|
|
|
|
( |
Profit before tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended June 30, 2023 |
|||||||||||
(In thousands of Euros) |
|
Americas |
|
Europe |
|
APMA |
|
|
Total Reportable Segments |
|
Corporate / Other |
|
Total |
Revenue |
|
|
|
|
|
|
|
||||||
Adjusted EBITDA |
|
|
|
|
|
|
( |
|
|||||
IPO-related costs |
|
|
|
|
|
|
|
|
|
|
|
|
( |
Realized and unrealized FX gains / losses |
|
|
|
|
|
|
|
|
|
|
|
|
( |
Share-based compensation expenses |
|
|
|
|
|
|
|
|
|
|
|
|
( |
Other |
|
|
|
|
|
|
|
|
|
|
|
|
( |
EBITDA |
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
|
|
( |
Finance cost, net |
|
|
|
|
|
|
|
|
|
|
|
|
( |
Profit before tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
9
6. PROPERTY, PLANT AND EQUIPMENT
7. RIGHT-OF-USE ASSETS
During the nine months ended June 30, 2024 and 2023, the Company added right-of-use assets with costs of €
8. INVENTORIES
|
|
|
|
|||||
(In thousands of Euros) |
|
June 30, |
|
|
September 30, |
|
||
Raw materials |
|
|
|
|
|
|
||
Work in progress |
|
|
|
|
|
|
||
Finished goods |
|
|
|
|
|
|
||
Total inventories at the lower of cost and net realizable value |
|
|
|
|
|
|
||
Write-downs of inventories during the three and nine months ended June 30, 2024 amounted to €
9. EQUITY
Initial Public Offering
On October 13, 2023, the Company closed its IPO. Birkenstock issued and sold
Capital Reorganization
In addition, on October 10, 2023, the Company entered into the TRA with MidCo in consideration for the repurchase of
As of October 13, 2023 and June 30, 2024, the Company had
Secondary Offering
On June 28, 2024, the Company completed a secondary offering of ordinary shares on behalf of MidCo ("selling shareholder") at a price of $
The Company did not issue additional ordinary shares and did not receive any proceeds from the secondary offering. The Company incurred €
10
10. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT
The following table presents the fair values and fair value hierarchy of the Company’s financial instruments that are carried at fair value on a recurring basis in the consolidated statements of financial position:
|
|
|
|
|
|
Fair value |
|
|||||
(In thousands of Euros) |
|
Level |
|
Measurement |
|
June 30, |
|
|
September 30, |
|
||
Derivative assets |
|
|
|
|
|
|
|
|
|
|
||
Derivative assets not designated as hedging instruments |
|
2 |
|
FVtPL |
|
|
|
|
|
|
||
Derivative assets designated as hedging instruments |
|
2 |
|
FVtOCI |
|
|
|
|
|
|
||
Derivative liabilities |
|
2 |
|
FVtPL |
|
|
|
|
|
|
||
Changes in fair value of derivative assets and liabilities are recognized within the consolidated statements of profit or loss except for changes in the fair value of derivative financial instruments designated as hedging instruments which are recognized within other comprehensive income.
During the three months ended June 30, 2024, the interest cap associated with the existing Euro-denominated Term Loan no longer qualified for hedge accounting and was terminated with the signing of the new Term Loans and new revolving credit facility. As such, the Company reclassified the cash flow hedge reserve of a cumulative loss of €
For details on the new financing, please refer to Note 11 - Loans and Borrowings.
The Company does not carry any further financial instruments at fair value either on a recurring or non-recurring basis. The derivative assets and liabilities are reflected in the statements of financial position within other assets, other current assets and other financial liabilities.
The following table presents the fair value and fair value hierarchy of the Company’s loans and borrowings carried at amortized cost:
(In thousands of Euros) |
|
Level |
|
Nominal value |
|
|
Carrying value |
|
|
Fair value |
|
|||
June 30, 2024 |
|
|
|
|
|
|
|
|
|
|
|
|||
Term Loan (EUR) |
|
2 |
|
|
|
|
|
|
|
|
|
|||
Term Loan (USD) |
|
2 |
|
|
|
|
|
|
|
|
|
|||
Vendor Loan |
|
2 |
|
|
|
|
|
|
|
|
|
|||
Senior Notes |
|
2 |
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|||
September 30, 2023 |
|
|
|
|
|
|
|
|
|
|
|
|||
Term Loan (EUR) |
|
2 |
|
|
|
|
|
|
|
|
|
|||
Term Loan (USD) |
|
2 |
|
|
|
|
|
|
|
|
|
|||
Vendor Loan |
|
2 |
|
|
|
|
|
|
|
|
|
|||
Senior Notes |
|
2 |
|
|
|
|
|
|
|
|
|
|||
There were
There were also no changes in the Company’s valuation processes, valuation techniques and types of inputs used in the fair value measurements during the reporting period.
Financial risk management
Birkenstock has exposure to credit risk, liquidity risk and market risk. The interim condensed consolidated financial statements do not include all financial risk information and disclosures required in the annual financial statements and should be read in conjunction with Birkenstock’s annual financial statements for the fiscal year ended September 30, 2023.
11
Capital management
The Board of Directors of the Company monitors the Company’s capital management on a regular basis. The Company continually assesses the adequacy of the Company’s capital structure and capacity and adjusts within the context of the Company’s strategy, economic conditions, and risk characteristics of the business.
11. LOANS AND BORROWINGS
The Company has the following principal and interest payable amounts outstanding for loans and borrowings:
|
|
|
|
|
|
|
|
|
|
|
||
(In thousands of Euros) |
|
Currency |
|
Year of maturity |
|
June 30, |
|
|
September 30, |
|
||
Non-current liabilities |
|
|
|
|
|
|
|
|
|
|
||
Term Loan (EUR) |
|
EUR |
|
|
|
|
|
|
|
|||
Term Loan (USD) |
|
USD |
|
|
|
|
|
|
|
|||
Vendor Loan |
|
EUR |
|
|
|
|
|
|
|
|||
Senior Notes |
|
EUR |
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
||
Senior Note embedded derivative |
|
|
|
|
|
|
|
|
|
|
||
Less: amortization under the effective interest method |
|
|
|
|
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
||
Current liabilities |
|
|
|
|
|
|
|
|
|
|
||
Term Loan (EUR) interest payable |
|
EUR |
|
|
|
|
|
|
|
|
||
Term Loan (USD) - current portion |
|
USD |
|
|
|
|
|
|
|
|
||
Term Loan (USD) interest payable |
|
USD |
|
|
|
|
|
|
|
|
||
Vendor Loan interest payable |
|
EUR |
|
|
|
|
|
|
|
|
||
Senior Notes interest payable |
|
EUR |
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
||
During the nine months ended June 30, 2024, the Company made early repayments of €
On May 28, 2024 Birkenstock Limited Partner S.à r.l., a subsidiary of the Company, entered into a term and revolving facilities agreement for a new syndicated credit facility consisting of a €
12. TAX RECEIVABLE AGREEMENT
On October 10, 2023, the Company entered into the Tax Receivable Agreement with MidCo (together with its permitted successors and assignees' shareholders, the "TRA Participants"). Pursuant to the TRA, the Company must make certain tax benefit payments (which are to be paid in cash in USD) to MidCo as consideration for the Company’s repurchase of
12
The future payments expected to be made under the TRA may total approximately $
In general, payments under the TRA are expected to be made only in periods following the filing of a tax return in which the Company is able to utilize certain tax benefits to reduce taxes paid to a tax authority. The impact of any changes in the projected obligations under the TRA as a result of changes in the future taxable income, changes in tax legislation or tax rates, or other factors that may impact the Company’s tax savings will be reflected in other income/ expense, net, in the condensed consolidated statements of comprehensive income in the period in which the change occurs. During the nine months ended June 30, 2024 there were no material changes in the the contractual obligation. Moreover, there were no changes in estimates with respect to the expected future cash payments to be made under the TRA for the three and nine months ended June 30, 2024.
Subsequent to its inception, the TRA is measured at amortized cost taking into consideration the current expected cash flows and the original effective interest rate. The liability is discounted via the effective-interest-method and the expenses are recognized within interest expenses. As payments under the TRA are to be made in USD, the TRA liability is remeasured to the Company's reporting currency at each reporting period, with foreign exchange gains or losses recognized in the statement of comprehensive income (loss). The ending balance of the TRA liability as of June 30, 2024 amounted to €
13. DEFERRED INCOME
In the fiscal year ended September 30, 2023 the Company was awarded a government grant by the State of Mecklenburg-Vorpommern, amounting up to €
14. REVENUE FROM CONTRACTS WITH CUSTOMERS
For disaggregation of revenue by geography refer to Note 5 – Segment information. Disaggregation of revenue by sales channels was as follows:
|
|
Three months ended June 30, |
|
|
Nine months ended June 30, |
|
||||||||||
(In thousands of Euros) |
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
B2B |
|
|
|
|
|
|
|
|
|
|
|
|
||||
DTC |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Other |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total revenue |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Our B2B and DTC channels generate revenue across each of our reportable segments, with B2B revenue being more prominent in each segment. In our Americas and Europe reportable segments, the distribution between B2B and DTC revenue approximates the distribution for the consolidated group. In our APMA reportable segment, the proportion of B2B revenue is greater than the distribution for the consolidated group.
13
15. OPERATING EXPENSES
|
|
Cost of sales |
|
|||||||||||||
|
|
Three months ended June 30, |
|
|
Nine months ended June 30, |
|
||||||||||
(In thousands of Euros) |
|
2024 |
|
|
2023* |
|
|
2024 |
|
|
2023* |
|
||||
Depreciation & amortization |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Personnel costs |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Cost of materials |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Maintenance costs |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Logistic expenses |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
IT & Consulting |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Other |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Cost of sales |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
Selling and distribution expenses |
|
|||||||||||||
|
|
Three months ended June 30, |
|
|
Nine months ended June 30, |
|
||||||||||
(In thousands of Euros) |
|
2024 |
|
|
2023* |
|
|
2024 |
|
|
2023* |
|
||||
Depreciation & amortization |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Personnel costs |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Marketing and selling expenses |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Logistic expenses |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
IT & Consulting |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Other |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Selling and distribution expenses |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
General administration expenses |
|
|||||||||||||
|
|
Three months ended June 30, |
|
|
Nine months ended June 30, |
|
||||||||||
(In thousands of Euros) |
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Depreciation & amortization |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Personnel costs |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Insurance |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
IT & Consulting |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Other |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
General administration expenses |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
*some FY2023 figures have been reclassified to be consistent with the FY2024 presentation.
16. INCOME TAX
The Company determined the reporting periods’ income tax expense based on an estimate of the annual effective income tax rate in the respective countries applied to the pre-tax result before the tax effect of any discrete items of this reporting period.
|
|
Three months ended June 30, |
|
|
Nine months ended June 30, |
|
||||||||||
(In thousands of Euros) |
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Current income taxes |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Deferred income taxes |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Income tax expense |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
The Company estimates the income tax rate for the fiscal year ending September 30, 2024 will be
14
For details on the TRA please refer to Note 12 - Tax Receivable Agreement.
17. EARNINGS PER SHARE
Basic and diluted earnings per share is calculated by dividing net profit (loss) attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the reporting period.
The calculation of earnings per share is as follows:
|
|
Three months ended June 30, |
|
|
Nine months ended June 30, |
|
||||||||||
(In thousands of Euros, except share and per share information) |
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Weighted number of outstanding shares |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Number of shares with dilutive effects |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Weighted number of outstanding shares (diluted and undiluted) |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net profit attributable to ordinary shareholders |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
||||
The Company's management investment plan has no dilutive effect on the earnings per share calculation as all granted awards are settled by an immediate parent rather than by the Company itself. For further information please refer to Note 18 – Share-based compensation.
18. SHARE-BASED COMPENSATION
In March 2023, awards for
The weighted average fair value of the awards granted under the management investment plan ("MIP") was €
As the Company closed its IPO on October 13, 2023, the entire award vested during the reporting period.
|
Three months ended June 30, |
|
|
Nine months ended June 30, |
|
||||||||||
(In thousands of Euros) |
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Sales and marketing expenses |
|
|
|
|
|
|
|
|
|
|
|
||||
General administrative expenses |
|
|
|
|
|
|
|
|
|
|
|
||||
Total |
|
|
|
|
|
|
|
|
|
|
|
||||
The Company paid personal income taxes of €
15
19. COMMITMENTS AND CONTINGENCIES
The Company is defending an action brought by a French distributor as a result of the termination of a business relationship. The plaintiff's initial claim amounted to €
20. RELATED PARTY
In the course of the Company’s ordinary business activities, the Company enters into related party transactions with its shareholders and key management personnel.
Parent and ultimate controlling party
The ultimate controlling party of the Company is L Catterton.
Transactions with key management personnel
Key management compensation
Key management personnel for the periods presented consisted of our Chief Executive Officer, Chief Financial Officer, Chief Communications Officer, Chief Legal Officer, Chief Product Officer, Chief Sales Officer, Chief Technical Operations Officer, President Europe, President Americas and the Board of Directors.
Key management compensation is comprised of the following:
|
|
Three months ended |
|
|
Nine months ended |
|
||||||||||
(In thousands of Euros) |
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Short-term employee benefits |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Long-term employee benefits |
|
|
|
|
|
|
|
|
— |
|
|
|
|
|||
Post-employment benefits |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Termination benefits |
|
|
( |
) |
|
|
|
|
|
( |
) |
|
|
|
||
Share-based compensation expenses |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total |
|
|
|
|
|
|
|
|
|
|
|
|
||||
The Company paid personal income taxes of €
During the three and nine months ended June 30, 2024, director compensation amounted to €
Key management personnel transactions
The Company maintains a long-term business relationship related to the production of advertising content with a model agency, owned by a family member of our Chief Executive Officer. During the nine months ended June 30, 2024 and 2023, the Company incurred marketing expenses in the amount of €
The Company leased administrative buildings from Ockenfels Group GmbH & Co. KG (“Ockenfels”), an entity managed by our Chief Executive Officer and controlled by the predecessor shareholders, AB-Beteiligungs GmbH and CB Beteiligungs GmbH & Co. KG, and made lease payments (equivalent to the expenses for the period) in the amount of €
16
the three months ended June 30, 2024 and 2023 and €
As of September 30, 2023, the Company had outstanding receivables of €
Other related party transactions
Transactions with other related parties primarily consisted of consulting fees for management services provided by and expenses reimbursed to L Catterton Management Company LLC and related entities controlled by the shareholders of the Company. The Company incurred €
As of June 30, 2024, the Company has a lease liability of €
As described in Note 12 - Tax Receivable Agreement, in October 2023 the Company entered into the TRA with the pre-IPO shareholder MidCo. There were no payments made under the TRA during the three and nine months ended June 30, 2024. The outstanding balance of the TRA liability as of June 30, 2024 was €
21. Subsequent Events
On July 3, 2024, as part of the secondary offering, the underwriters exercised their option to purchase an additional
The Company did not issue additional ordinary shares, did not receive any proceeds from the secondary offering, and did not incur any additional costs for the exercise of this option.
17
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion of our financial condition and results of operations should be read in conjunction with the unaudited interim condensed consolidated financial statements and the related notes to those statements included in Item 1 of this Report on Form 6-K (the "Report"). We also recommend that you read our discussion and analysis of financial condition and results of operations together with our audited financial statements and the notes thereto, and the section entitled “Risk Factors”, each of which appear in our annual report on Form 20-F for the year ended September 30, 2023 as filed with the SEC on January 18, 2024 ("Annual Report"). As discussed in the section titled "Cautionary Statement Regarding Forward-Looking Statements," the following discussion and analysis contains forward looking statements that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, those identified below in such section.
Rounding adjustments were made to some of the figures included in this document. Accordingly, numerical figures shown as totals in some tables may not be an arithmetic aggregation of the figures that preceded them. With respect to financial information set out in this document, a dash (“—”) signifies that the relevant figure is not available or not applicable, while a zero (“0.0”) signifies that the relevant figure is available but is or has been rounded to zero.
A. OPERATING RESULTS
Overview
BIRKENSTOCK is a revered global brand rooted in function, quality and tradition dating back to 1774. We are guided by a simple, yet fundamental insight: human beings are intended to walk barefoot on natural, yielding ground, a concept we refer to as “Naturgewolltes Gehen.” Our purpose is to empower all people to walk as intended by nature. The legendary BIRKENSTOCK footbed represents the best alternative to walking barefoot, encouraging proper foot health by evenly distributing weight and reducing pressure points and friction. We believe our function-first approach is universally relevant; all humans — anywhere and everywhere — deserve to walk in our footbed.
We primarily generate revenue through the sale of footbed-based products from our broad portfolio of over 700 silhouettes, anchored by our iconic Core Silhouettes, the Madrid, Arizona, Boston, Gizeh and Mayari. We engineer and produce 100% of our products in the EU through our vertically integrated manufacturing operations, thereby ensuring each pair sold meets our rigorous quality standards. Our materials and components are primarily sourced from suppliers in Europe and processed under the highest environmental and social standards in the industry.
Our strongest, most developed segments are the Americas and Europe, which represented 50% and 38% of revenue, respectively, for the three months ended June 30, 2024,and 53% and 35% of revenue, respectively, for the nine months ended June 30, 2024. Our APMA segment has demonstrated considerable growth potential, which has not been fully realized historically due to the finite nature of our product supply as a result of limited production capacities, and our deliberate decisions to prioritize the Americas and Europe segments.
We optimize growth and profitability through a multi-channel DTC and B2B distribution strategy that we refer to as engineered distribution. We operate our channels synergistically, seeking to grow both simultaneously. We utilize the B2B channel to facilitate brand accessibility while steering consumers to our DTC channel, which offers our complete product range and access to our most desired and unique silhouettes. Across both channels, we execute a strategic allocation and product segmentation process, often down to the single door level, to ensure we sell the right product in the right channel at the right price point. This approach is centered on the strategic calibration of our average selling price ("ASP") and employs key levers such as the expansion of our DTC channel, market conversions from third-party distributors, optimization of our wholesale partner network, increased overall share of premium products and strategic pricing. This process allows us to manage the finite nature of our production capacity with a rigorous focus on control of our brand image and profitability. As a result, we drive top-line growth and margins, prevent brand dilution and deepen our connection to consumers.
Our DTC footprint promotes direct consumer relationships and provides access to BIRKENSTOCK in its purest form. Our DTC channel enables us to express our brand identity, engage directly with our global fan base, capture real-time data on customer behavior and provide consumers with unique product access to our most distinctive styles. Additionally, our high levels of organic demand creation, together with higher ASPs, support consistently attractive profitability in the DTC channel.
18
Our wholesale strategy is defined by intentionality in partner selection and identifying the best partners in each segment and price point. We segment our wholesale product line availability into specific retailer quality tiers, ensuring we allocate the right product to the right channel for the right consumer. For example, we limit access to our premium 1774 and certain collaboration products to a curated group of brand partners.
For our wholesale partners, we are a “must carry” brand based on the enthusiasm with which our consumers pursue our products, as evidenced by our brand consistently being amongst the top performers in our core categories at most of our retail partners. We generate significantly more demand from existing and prospective wholesale customers than we can supply, putting us in an enviable position where we can create scarcity in the market and obtain favorable economic terms on wholesale distribution. The early placement of wholesale orders effectively determines sales to the end-consumer approximately six months in advance and aids in our production planning and allocation. In addition, sell-through transparency from important wholesalers provides real-time insight into the overall market and inventory dynamics.
In October 2023, we successfully completed our IPO. The proceeds from the IPO were $473.6 million after deducting underwriting discounts and commissions but before deducting expenses. We used the proceeds from the IPO, together with cash on hand, to repay €100.0 million in aggregate principal amount of the Vendor Loan and $450.0 million in aggregate principal amount of borrowings outstanding under the USD TLB Facility.
Key Financial Highlights
Key highlights for the three months ended June 30, 2024 compared to the three months ended June 30, 2023 include:
Non-IFRS Financial Measures
We report our financial results in accordance with IFRS; however, management believes that certain non-IFRS financial measures provide useful information in measuring the operating performance and financial condition of the Company and are used by management to make decisions. Management believes this information presents helpful comparisons of financial performance between periods by excluding the effect of certain non-recurring items.
We use non-IFRS financial measures, such as Constant currency revenue, Constant currency revenue growth, Adjusted EBITDA, Adjusted EBITDA margin, Adjusted net profit (loss), Adjusted net profit (loss) margin and Adjusted basic
19
/ diluted earnings (loss) per share to supplement financial information presented in accordance with IFRS. We believe that excluding certain items from our IFRS results allows management to better understand our consolidated financial performance from period-to-period and better project our future consolidated financial performance as forecasts are developed at a level of detail different from that used to prepare IFRS-based financial measures. Moreover, we believe these non-IFRS financial measures provide our stakeholders with useful information to help them evaluate our operating results by facilitating an enhanced understanding of our operating performance and enabling them to make more meaningful period-to-period comparisons.
These measures do not have a standardized meaning prescribed by IFRS and therefore they may not be comparable to similarly titled measures presented by other companies, and they should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with IFRS.
Constant Currency Revenue and Constant Currency Revenue Growth
|
Three months ended June 30, |
|
|
Nine months ended June 30, |
|
||||||||
(In thousands of Euros) |
2024 |
|
2023 |
|
|
2024 |
|
2023 |
|
||||
Revenue |
|
564,758 |
|
|
473,195 |
|
|
|
1,348,926 |
|
|
1,117,368 |
|
Revenue, constant currency |
|
563,641 |
|
|
477,948 |
|
|
|
1,362,634 |
|
|
1,098,208 |
|
Revenue growth, constant currency |
|
19 |
% |
|
26 |
% |
|
|
22 |
% |
|
19 |
% |
Our reporting currency is the Euro, and changes in foreign exchange rates can significantly affect our reported results and consolidated trends. The majority of non-Euro transactions are denominated in USD.
The effect of currency exchange rates on our business is an important factor in understanding period-to-period comparisons, which in turn are used in financial and operational decision-making. By viewing our results of operations on a constant currency basis, the effects of foreign currency volatility, which is not indicative of our actual results of operations, are eliminated, enhancing the ability to understand our operating performance.
Constant currency information compares results between periods as if exchange rates had remained constant. We define Constant currency revenue as total revenue excluding the effect of foreign exchange rate movements and use them to determine Constant currency revenue growth on a comparative basis. Constant currency revenue is calculated by translating the current period foreign currency revenue using the prior period exchange rate. Constant currency revenue growth is calculated by determining the increase in current period revenue over prior period revenue, where current period foreign currency revenue is translated using prior period exchange rates. For example, USD denominated constant currency revenue for the three months ended June 30, 2024 and the three months ended June 30, 2023 was calculated using the exchange rate of $1.08 to €1 and $1.09 to €1, respectively.
Reconciliation of Constant Currency Revenue to Revenue
The table below presents a reconciliation of constant currency revenue to the most comparable IFRS measure, revenue, for the periods presented.
|
Three months ended June 30, |
|
|
Nine months ended June 30, |
|
||||||||
(In thousands of Euros) |
2024 |
|
2023 |
|
|
2024 |
|
2023 |
|
||||
Revenue |
|
564,758 |
|
|
473,195 |
|
|
|
1,348,926 |
|
|
1,117,368 |
|
Add (Less): |
|
|
|
|
|
|
|
|
|
||||
U.S. Dollar impact |
|
(2,929 |
) |
|
750 |
|
|
|
9,175 |
|
|
(24,394 |
) |
Canadian Dollar impact |
|
403 |
|
|
1,448 |
|
|
|
1,721 |
|
|
1,119 |
|
Other |
|
1,410 |
|
|
2,555 |
|
|
|
2,813 |
|
|
4,115 |
|
Constant currency revenue |
|
563,641 |
|
|
477,948 |
|
|
|
1,362,634 |
|
|
1,098,208 |
|
20
|
Three months ended June 30, |
|
|
Constant Currency Growth [%] |
|
(In thousands of Euros) |
2024 |
2023 |
|
Growth [%] |
|
B2B |
340,593 |
275,655 |
|
24% |
23% |
DTC |
223,364 |
196,441 |
|
14% |
14% |
Corporate / Other |
801 |
1,099 |
|
(27)% |
(27)% |
Total Revenue |
564,758 |
473,195 |
|
19% |
19% |
Americas |
282,865 |
244,101 |
|
16% |
15% |
Europe |
217,405 |
181,274 |
|
20% |
19% |
APMA |
63,687 |
46,721 |
|
36% |
41% |
Corporate / Other |
801 |
1,099 |
|
(27)% |
(27)% |
Total Revenue |
564,758 |
473,195 |
|
19% |
19% |
|
Nine months ended June 30, |
|
|
Constant Currency Growth [%] |
|
(In thousands of Euros) |
2024 |
2023 |
|
Growth [%] |
|
B2B |
843,527 |
697,400 |
|
21% |
22% |
DTC |
501,792 |
416,138 |
|
21% |
23% |
Corporate / Other |
3,607 |
3,830 |
|
(6)% |
(6)% |
Total Revenue |
1,348,926 |
1,117,368 |
|
21% |
22% |
Americas |
718,364 |
617,452 |
|
16% |
18% |
Europe |
473,081 |
386,044 |
|
23% |
22% |
APMA |
153,874 |
110,042 |
|
40% |
44% |
Corporate / Other |
3,607 |
3,830 |
|
(6)% |
(6)% |
Total Revenue |
1,348,926 |
1,117,368 |
|
21% |
22% |
Adjusted EBITDA and Adjusted EBITDA Margin
|
Three months ended June 30, |
|
|
Nine months ended June 30, |
|
||||||||
(In thousands of Euros) |
2024 |
|
2023 |
|
|
2024 |
|
2023 |
|
||||
Adjusted EBITDA |
|
186,329 |
|
|
162,636 |
|
|
|
429,982 |
|
|
387,017 |
|
Adjusted EBITDA margin |
|
33.0 |
% |
|
34.4 |
% |
|
|
31.9 |
% |
|
34.6 |
% |
Adjusted EBITDA is defined as net profit for the period adjusted for income tax expense, finance cost net, depreciation and amortization, further adjusted for the effect of events such as:
21
Reconciliation of Net Profit to Adjusted EBITDA
The table below presents a reconciliation of net profit to Adjusted EBITDA for the periods presented:
|
Three months ended June 30, |
|
|
Nine months ended June 30, |
|
||||||||
(In thousands of Euros) |
2024 |
|
2023 |
|
|
2024 |
|
2023 |
|
||||
Net profit (loss) |
|
74,640 |
|
|
63,102 |
|
|
|
139,137 |
|
|
103,309 |
|
Add (Less): |
|
|
|
|
|
|
|
|
|
||||
Income tax expense (benefit) |
|
36,255 |
|
|
28,215 |
|
|
|
76,399 |
|
|
50,914 |
|
Finance cost, net |
|
44,578 |
|
|
26,694 |
|
|
|
108,017 |
|
|
81,358 |
|
Depreciation and amortization |
|
24,809 |
|
|
21,233 |
|
|
|
72,193 |
|
|
61,807 |
|
EBITDA |
|
180,282 |
|
|
139,244 |
|
|
|
395,746 |
|
|
297,388 |
|
Add (Less) Adjustments: |
|
|
|
|
|
|
|
|
|
||||
Share-based compensation expenses(1) |
|
— |
|
|
14,817 |
|
|
|
3,591 |
|
|
18,085 |
|
Relocation expenses(2) |
|
— |
|
|
(268 |
) |
|
|
— |
|
|
3,502 |
|
Restructuring expenses(3) |
|
— |
|
|
— |
|
|
|
— |
|
|
1,953 |
|
IPO-related costs(4) |
|
— |
|
|
5,247 |
|
|
|
7,460 |
|
|
14,739 |
|
Secondary offering related costs(5) |
|
1,890 |
|
|
— |
|
|
|
1,890 |
|
|
— |
|
Realized and unrealized FX gains / losses(6) |
|
4,157 |
|
|
3,596 |
|
|
|
21,295 |
|
|
51,350 |
|
Adjusted EBITDA |
|
186,329 |
|
|
162,636 |
|
|
|
429,982 |
|
|
387,017 |
|
Adjusted Net Profit (Loss) and Adjusted Net Profit (Loss) Margin
|
Three months ended June 30, |
|
|
Nine months ended June 30, |
|
||||||||
(In thousands of Euros) |
2024 |
|
2023 |
|
|
2024 |
|
2023 |
|
||||
Adjusted net profit (loss) |
|
91,870 |
|
|
80,421 |
|
|
|
185,603 |
|
|
182,018 |
|
Adjusted net profit (loss) margin |
|
16.3 |
% |
|
17.0 |
% |
|
|
13.8 |
% |
|
16.3 |
% |
We define Adjusted net profit (loss) as Net profit (loss) for the period adjusted for IPO-related costs, realized and unrealized foreign exchange gain (loss), share-based compensation expenses, relocation expenses, the release of capitalized transaction costs and the respective income tax effects as applicable. Adjusted net profit (loss) margin is defined as Adjusted net profit (loss) for the period divided by revenue for the same period.
22
Reconciliation of Net Profit (Loss) to Adjusted Net Profit (Loss)
The table below presents a reconciliation of Net profit (loss) to Adjusted net profit (loss) for the periods presented:
|
Three months ended June 30, |
|
|
Nine months ended June 30, |
|
||||||||
(In thousands of Euros) |
2024 |
|
2023 |
|
|
2024 |
|
2023 |
|
||||
Net profit (loss) |
|
74,640 |
|
|
63,102 |
|
|
|
139,137 |
|
|
103,309 |
|
Add (Less) Adjustments: |
|
|
|
|
|
|
|
|
|
||||
Share-based compensation expenses(1) |
|
— |
|
|
14,817 |
|
|
|
3,591 |
|
|
18,085 |
|
Relocation expenses(2) |
|
— |
|
|
(268 |
) |
|
|
— |
|
|
3,502 |
|
Restructuring expenses(3) |
|
— |
|
|
— |
|
|
|
— |
|
|
1,953 |
|
IPO-related costs(4) |
|
— |
|
|
5,247 |
|
|
|
7,460 |
|
|
14,739 |
|
Secondary offering related costs(5) |
|
1,890 |
|
|
— |
|
|
|
1,890 |
|
|
— |
|
Realized and unrealized FX gains / losses(6) |
|
4,157 |
|
|
3,596 |
|
|
|
21,295 |
|
|
51,350 |
|
Release of capitalized transaction costs(7) |
|
16,310 |
|
|
— |
|
|
|
26,858 |
|
|
— |
|
Tax adjustment(8) |
|
(5,127 |
) |
|
(6,073 |
) |
|
|
(14,627 |
) |
|
(10,920 |
) |
Adjusted net profit (loss) |
|
91,870 |
|
|
80,421 |
|
|
|
185,603 |
|
|
182,018 |
|
Adjusted Basic / Diluted Earnings (Loss) Per Share
|
Three months ended June 30, |
|
Nine months ended June 30, |
||
(In Euros) |
2024 |
2023 |
|
2024 |
2023 |
Adjusted earnings (loss) per share |
|
|
|
|
|
Basic |
0.49 |
0.44 |
|
0.99 |
1.00 |
Diluted |
0.49 |
0.44 |
|
0.99 |
1.00 |
We define Adjusted earnings (loss) per share as Adjusted net profit (loss) for the period divided by the weighted number of shares outstanding.
23
Reconciliation of Net Profit (Loss) to Adjusted Earnings (Loss) per share
The table below presents a reconciliation of Adjusted earnings (loss) per share to the most comparable IFRS measure, Net profit (loss), for the periods presented:
(In thousands of Euros, except share and per share information) |
Three months ended June 30, |
|
Nine months ended June 30, |
||
|
2024 |
2023 |
|
2024 |
2023 |
Net profit (loss) |
74,640 |
63,102 |
|
139,137 |
103,309 |
Add (Less) Adjustments: |
|
|
|
|
|
Share-based compensation expenses(1) |
— |
14,817 |
|
3,591 |
18,085 |
Relocation expenses(2) |
— |
(268) |
|
— |
3,502 |
Restructuring expenses(3) |
— |
— |
|
— |
1,953 |
IPO-related costs(4) |
— |
5,247 |
|
7,460 |
14,739 |
Secondary offering related costs(5) |
1,890 |
— |
|
1,890 |
— |
Realized and unrealized FX gains / losses(6) |
4,157 |
3,596 |
|
21,295 |
51,350 |
Release of capitalized transaction costs(7) |
16,310 |
— |
|
26,858 |
— |
Tax adjustment(8) |
(5,127) |
(6,073) |
|
(14,627) |
(10,920) |
Adjusted net profit (loss) |
91,870 |
80,421 |
|
185,603 |
182,018 |
Weighted number of outstanding shares (diluted and undiluted) |
187,827,437 |
182,721,369 |
|
187,522,182 |
182,721,369 |
Adjusted earnings (loss) per share |
|
|
|
|
|
Basic |
0.49 |
0.44 |
|
0.99 |
1.00 |
Diluted |
0.49 |
0.44 |
|
0.99 |
1.00 |
Segments
Our three reportable segments align with our geographic operational hubs: the Americas, Europe, and APMA as described above, which contributed 50%, 38%, and 11% of revenue, respectively, for the three months ended June 30, 2024 and 53%, 35%, and 11% of revenue, respectively for the nine months ended June 30, 2024 . The Americas includes, among other markets, the United States, Brazil, Canada and Mexico. The United States is our largest and most important market in the Americas. Europe includes, among others, the key markets of Germany, France and the UK. Germany, the country of our primary operations and where the BIRKENSTOCK brand originated, accounts for the largest percentage of revenue in Europe. The largest markets in APMA include Australia, Japan, China, United Arab Emirates and India.
Revenue and costs not directly managed nor allocated to the geographic operational hubs are recorded in Corporate/Other. Corporate/Other immaterially contributed to our revenue during the three and nine months ended June 30, 2024.
24
Components of our Results of Operations
Revenue
Revenue is primarily recognized from the sale of our products, including sandals, closed-toe silhouettes and other products, such as skincare and accessories.
We are currently distributing across three reporting segments: Americas, Europe and APMA. Within each segment, we manage a multi-channel distribution strategy, divided between our DTC and B2B channels. Both channels are important to our strategy and provide differentiated economic benefits and insights.
B2B revenue is recognized when control of the goods has transferred, depending on the agreement with the customer. Following the transfer of control, the customer has the responsibility to sell the goods and bears the risks of obsolescence and loss in relation to the goods.
DTC channel revenue is recognized when control of the goods has transferred, either upon delivery to e-commerce consumers or at the point of sale in retail stores. Payment of the transaction price is due immediately when the consumer purchases the goods. When the control of goods has transferred, a refund liability recorded in other current financial liabilities and a corresponding adjustment to revenue is recognized for those products expected to be returned. The Company has a right to recover the product when consumers exercise their right of return, which results in recognizing a right to return goods asset included in other current assets and a corresponding reduction to cost of sales.
Other revenue is comprised of revenue not directly allocated to the geographical operating segments, as well as revenue generated by non-product categories. These categories include skincare and license revenue from fees paid to us by our licensees in exchange for the use of our trademarks on their products (primarily our sleep systems business). In addition, other revenue consist of revenue from real estate rentals and the sale of recyclable scrap materials from the production process.
Cost of sales
Cost of sales is comprised primarily of four types of expenditures: (i) raw materials, (ii) consumables and supplies, (iii) purchased merchandise and (iv) personnel costs, including temporary personnel services. Additionally, it includes overhead costs for the production sites. Freight charges for transfer of work-in-progress inventory between production plants, logistical centers and warehouses as well as inbound freight for raw materials are also included in cost of sales. Cost of sales reflect the portion of costs which correspond to the units sold in a given period.
Gross profit and gross profit margin
Gross profit is revenue less cost of sales and gross profit margin measures our gross profit as a percentage of revenue.
Selling and distribution expenses
Selling and distribution expenses are comprised of our selling, marketing, product innovation and supply chain costs. These expenses are incurred to support and expand our wholesale partner relationships, grow brand awareness and deliver our products to B2B partners, e-commerce consumers and retail stores. These expenses include personnel expenses for sales representatives, processing fees in the DTC channel and depreciation and amortization expenses for store leases, customer relationships and other intangible assets.
Selling costs generally correlate with revenue recognition timing and, therefore, experience similar seasonal trends to revenue with the exception of retail store costs, which are primarily fixed and incurred evenly throughout the year. As a percentage of revenue, we expect these selling costs to increase modestly as our business evolves. This increase is expected to be driven primarily by the relative growth of our DTC channel, including the investment required to support additional e-commerce sites and retail stores.
Distribution expenses are largely variable in nature and primarily relate to leasing and third-party expenses for warehousing inventories and transportation costs associated with delivering products from distribution centers to B2B partners and end-consumers.
25
General administrative expenses
General administrative expenses consist of costs incurred in our corporate service functions, such as costs relating to the finance department, legal and consulting fees, HR and IT expenses and global strategic project costs. More specifically, the nature of these costs relates to corporate personnel costs (including salaries, variable incentive compensation and benefits), other professional service costs, rental and leasing expenses for corporate real estate, depreciation and amortization related to software, patents and other rights. General administrative expenses will increase as we grow and become a publicly traded company. We expect these expenses to decrease as a percentage of revenue as we grow due to economies of scale.
Foreign exchange gain/(loss)
The foreign currency exchange gain/(loss) consists primarily of differences in foreign exchange rates between the currencies in which our subsidiaries transact and their functional currencies as measured on the respective transaction date.
Finance income/(cost), net
Finance income represents interest earned from third party providers and income from the potential revaluation of the embedded derivative of the Notes.
Finance costs are comprised of interest payable to third party providers for term loan financing arrangements, Notes, Vendor Loan, leases, employee benefits, as well as expenses from the potential revaluation of the embedded derivative of the Notes. Finance costs are recognized in the consolidated income statement based on the effective interest method.
Income tax (expense) benefit
Income tax includes current income tax and income tax credits from deferred tax. Income tax is recognized in profit and loss except to the extent that it relates to items recognized in equity or other comprehensive income in which case the income tax expense is also recognized in equity or other comprehensive income. We are subject to income taxes in the jurisdictions in which we operate and, consequently, income tax expense is a function of the allocation of taxable income by jurisdiction and the various activities that impact the timing of taxable events. Our subsidiaries in Germany and the U.S. primarily determine the effective tax rate.
Results of Operations
Comparison of the three and nine months ended June 30, 2024 and June 30, 2023
|
|
Three months ended June 30, |
|
Nine months ended June 30, |
||||||||||||
(In thousands of Euros) |
|
2024 |
|
2023 |
|
Change |
|
% Change |
|
2024 |
|
2023 |
|
Change |
|
% Change |
Revenue |
|
564,758 |
|
473,195 |
|
91,563 |
|
19% |
|
1,348,926 |
|
1,117,368 |
|
231,558 |
|
21% |
Cost of sales |
|
(228,833) |
|
(181,129) |
|
(47,704) |
|
26% |
|
(556,973) |
|
(436,532) |
|
(120,441) |
|
28% |
Gross profit |
|
335,925 |
|
292,066 |
|
43,859 |
|
15% |
|
791,953 |
|
680,836 |
|
111,117 |
|
16% |
Operating expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling and distribution expenses |
|
(149,185) |
|
(136,654) |
|
(12,531) |
|
9% |
|
(365,824) |
|
(309,521) |
|
(56,303) |
|
18% |
General administration expenses |
|
(27,377) |
|
(32,312) |
|
4,935 |
|
(15)% |
|
(81,754) |
|
(86,836) |
|
5,082 |
|
(6)% |
Foreign exchange gain (loss) |
|
(4,157) |
|
(3,596) |
|
(561) |
|
16% |
|
(21,295) |
|
(51,350) |
|
30,055 |
|
(59)% |
Other income (loss), net |
|
267 |
|
(1,493) |
|
1,760 |
|
(118)% |
|
473 |
|
2,452 |
|
(1,979) |
|
(81)% |
Profit from operations |
|
155,473 |
|
118,011 |
|
37,462 |
|
32% |
|
323,553 |
|
235,581 |
|
87,972 |
|
37% |
Finance cost, net |
|
(44,578) |
|
(26,694) |
|
(17,884) |
|
67% |
|
(108,017) |
|
(81,358) |
|
(26,659) |
|
33% |
Profit (loss) before tax |
|
110,895 |
|
91,317 |
|
19,578 |
|
21% |
|
215,536 |
|
154,223 |
|
61,313 |
|
40% |
Income tax (expense) |
|
(36,255) |
|
(28,215) |
|
(8,040) |
|
28% |
|
(76,399) |
|
(50,914) |
|
(25,485) |
|
50% |
Net profit (loss) |
|
74,640 |
|
63,102 |
|
11,538 |
|
18% |
|
139,137 |
|
103,309 |
|
35,828 |
|
35% |
26
Revenue
Revenue for the three months ended June 30, 2024 increased by €91.6 million, or 19%, to €564.8 million from €473.2 million for the three months ended June 30, 2023, and Revenue for the nine months ended June 30, 2024 increased by €231.6 million, or 21%, to €1,348.9 million from €1,117.4 million for the nine months ended June 30, 2023, driven by both unit and ASP growth and growing demand across all product categories, channels and segments throughout the quarter. Revenue growth was particularly strong in the APMA segment with a growth of 36% for the three months ended June 30, 2024 and a growth of 40% for the nine months ended June 30, 2024. For the three months ended June 30, 2024 the DTC channel grew by 14%, resulting in a DTC penetration of 40% for the three months ended June 30, 2024, compared to a DTC penetration of 42% for the three months ended June 30, 2023. For the nine months ended June 30, 2024 the DTC channel grew by 21%, with the DTC penetration at 37% for the nine months ended June 30, 2023 and nine months ended June 30, 2024.
Revenue for the three months ended June 30, 2024, as compared to the three months ended June 30, 2023, increased by 19% on a constant currency basis, whereas revenue during the nine months ended June 30, 2024 as compared to the nine months ended June 30, 2023 increased by 22% on a constant currency basis.
Revenue by channel
|
|
Three months ended June 30, |
|
Nine months ended June 30, |
||||||||||||
(In thousands of Euros) |
|
2024 |
|
2023 |
|
Change |
|
% Change |
|
2024 |
|
2023 |
|
Change |
|
% Change |
B2B |
|
340,593 |
|
275,655 |
|
64,938 |
|
24% |
|
843,527 |
|
697,400 |
|
146,127 |
|
21% |
DTC |
|
223,364 |
|
196,441 |
|
26,923 |
|
14% |
|
501,792 |
|
416,138 |
|
85,654 |
|
21% |
Corporate / Other |
|
801 |
|
1,099 |
|
(298) |
|
(27)% |
|
3,607 |
|
3,830 |
|
(223) |
|
(6)% |
Total Revenue |
|
564,758 |
|
473,195 |
|
91,563 |
|
19% |
|
1,348,926 |
|
1,117,368 |
|
231,558 |
|
21% |
Revenue generated by our B2B channel for the three months ended June 30, 2024 increased by €64.9 million, or 24%, to €340.6 million from €275.7 million for the three months ended June 30, 2023. Revenue generated by our B2B channel for the nine months ended June 30, 2024 increased by €146.1 million, or 21%, to €843.5 million from €697.4 million for the nine months ended June 30, 2023.The increase was driven by strong growth across all regions and mainly with existing partners.
Revenue generated by our DTC channel for the three months ended June 30, 2024 increased by €26.9 million, or 14%, to €223.4 million from €196.4 million for the three months ended June 30, 2023. Revenue generated by our DTC channel for the nine months ended June 30, 2024 increased by €85.7 million, or 21%, to €501.8 million from €416.1 million for the nine months ended June 30, 2023.The increase was attributable to growth across all regions, in particular in APMA, increased traffic and higher average order values resulting from price increases and product mix.
Other revenue for the three months ended June 30, 2024 decreased by €0.3 million, or 27%, to €0.8 million from €1.1 million for the three months ended June 30, 2023. Other revenue for the nine months ended June 30, 2024 decreased by €0.2 million, or 6%, to €3.6 million from €3.8 million for the nine months ended June 30, 2023. The developments in Other revenue were primarily attributable to sales of leather material to our supplier for footbed cuttings, as well as sales of recyclable scrap materials from the production process.
Cost of sales
|
|
Three months ended June 30, |
|
Nine months ended June 30, |
||||||||||||
(In thousands of Euros) |
|
2024 |
|
2023 |
|
Change |
|
% Change |
|
2024 |
|
2023 |
|
Change |
|
% Change |
Cost of sales |
|
(228,833) |
|
(181,129) |
|
(47,704) |
|
26% |
|
(556,973) |
|
(436,532) |
|
(120,441) |
|
28% |
Cost of sales for the three months ended June 30, 2024 increased by €47.7 million, or 26%, to €228.8 million from €181.1 million for the three months ended June 30, 2023. Cost of sales for the nine months ended June 30, 2024 increased by €120.4 million, or 28%, to €557.0 million from €436.5 million for the nine months ended June 30, 2023. The increase was primarily attributable to an increase in number of units sold, an increased share of premium products and the planned, temporary under-absorption from ongoing capacity expansion.
Gross profit and gross profit margin
|
|
Three months ended June 30, |
|
Nine months ended June 30, |
||||||||||||
(In thousands of Euros) |
|
2024 |
|
2023 |
|
Change |
|
% Change |
|
2024 |
|
2023 |
|
Change |
|
% Change |
Gross profit |
|
335,925 |
|
292,066 |
|
43,859 |
|
15% |
|
791,953 |
|
680,836 |
|
111,117 |
|
16% |
Gross profit margin |
|
59.5% |
|
61.7% |
|
(2.2) |
pp |
|
|
58.7% |
|
60.9% |
|
(2.2) |
pp |
|
27
Gross profit for the three months ended June 30, 2024 increased by €43.9 million, or 15%, to €335.9 million from €292.1 million for the three months ended June 30, 2023. Gross profit margin for the three months ended June 30, 2024 contracted by 2.2 percentage points to 59.5% from 61.7% for the three months ended June 30, 2023.
Gross profit for the nine months ended June 30, 2024 increased by €111.1 million, or 16%, to €792.0 million from €680.8 million for the nine months ended June 30, 2023. Gross profit margin for the nine months ended June 30, 2024 contracted by 2.2 percentage points to 58.7% from 60.9% for the nine months ended June 30, 2023.
The contraction in gross profit margin mainly reflects the planned, temporary under-absorption from ongoing production capacity expansion and a lower DTC penetration in the three months ended June 30, 2024.
Selling and distribution expenses
|
|
Three months ended June 30, |
|
Nine months ended June 30, |
||||||||||||
(In thousands of Euros) |
|
2024 |
|
2023 |
|
Change |
|
% Change |
|
2024 |
|
2023 |
|
Change |
|
% Change |
Selling and distribution expenses |
|
(149,185) |
|
(136,654) |
|
(12,531) |
|
9% |
|
(365,824) |
|
(309,521) |
|
(56,303) |
|
18% |
Selling and distribution expenses for the three months ended June 30, 2024 increased by €12.5 million, or 9%, to €149.2 million from €136.7 million for the three months ended June 30, 2023. Selling and distribution expenses for the three months ended June 30, 2024 increased at a slower rate than revenue, thus decreasing to 26.4% of revenue compared to 28.9% of revenue for the three months ended June 30, 2023 mainly driven by a higher share of B2B revenue with lower Selling and distribution expenses in B2B compared to DTC, primarily due to reduced last-mile shipping and performance marketing costs.
Selling and distribution expenses for the nine months ended June 30, 2024 increased by €56.3 million, or 18%, to €365.8 million from €309.5 million for the nine months ended June 30, 2023. The increase was primarily driven by revenue growth and retail expansion investments. Selling and distribution expenses for the nine months ended June 30, 2024 increased at a slower rate than revenue, to 27.1% of revenue compared to 27.7% of revenue for nine months ended June 30, 2023 due to non-recurring relocation expenses of €3.5 million for the nine months ended June 30, 2023 but not in the nine months ended June 30, 2024, as well as share-based compensation expenses of €2.0 million, which were incurred in the nine months ended June 30, 2023 as compared to €0.4 million in the nine months ended June 30, 2024.
General administration expenses
|
|
Three months ended June 30, |
|
Nine months ended June 30, |
||||||||||||
(In thousands of Euros) |
|
2024 |
|
2023 |
|
Change |
|
% Change |
|
2024 |
|
2023 |
|
Change |
|
% Change |
General administration expenses |
|
(27,377) |
|
(32,312) |
|
4,935 |
|
(15)% |
|
(81,754) |
|
(86,836) |
|
5,082 |
|
(6)% |
General administration expenses for the three months ended June 30, 2024 decreased by €4.9 million, or 15%, to €27.4 million from €32.3 million for the three months ended June 30, 2023. As a percentage of revenue, general administration expenses decreased by 2.0 percentage points to 4.8% for the three months ended June 30, 2024 from 6.8% for the three months ended June 30, 2023. The decrease in general administration expenses was primarily driven by non-recurring IPO-related costs of €5.2 million and expenses related to the management investment plan of €13.1 million, which were both incurred in the three months ended June 30, 2023 but not in the three months ended June 30, 2024.
General administration expenses for the nine months ended June 30, 2024 decreased by €5.1 million to €81.8 million from €86.8 million for the nine months ended June 30, 2023.
Foreign exchange gain (loss)
Foreign exchange loss, net for the three months ended June 30, 2024 increased by €0.6 million to €4.2 million from €3.6 million for the three months ended June 30, 2023. The overall increase in foreign exchange loss was primarily driven by a slightly more pronounced appreciation of the USD relative to the Euro for the three months ended June 30, 2024 as compared to the three months ended June 30, 2023.
Foreign exchange loss, net for the nine months ended June 30, 2024 decreased by €30.1 million to €21.3 million from €51.4 million for the nine months ended June 30, 2023. The overall decrease in foreign exchange loss was primarily driven by a more pronounced depreciation of the USD relative to the Euro for the nine months ended June 30, 2024 as compared to the nine months ended June 30, 2023.
28
Finance cost, net
Finance cost, net for the three months ended June 30, 2024 increased by €17.9 million, or 67%, to €44.6 million from €26.7 million for the three months ended June 30, 2023. The increase was primarily attributable to the accelerated amortization of €16.3 million capitalized transaction costs as a result of the early full repayment and refinancing of the EUR TLB facility, USD TLB facility, and ABL facility on August 2, 2024 as well as the additional interest expense related to the tax receivable agreement (TRA) of €13.8 million. These effects were partially offset by a decrease in interest expenses due to the early repayment of the USD TLB facility.
Finance cost, net for the nine months ended June 30, 2024 increased by €26.7 million, or 33%, to €108.0 million from €81.4 million for the nine months ended June 30, 2023. The increase was primarily attributable to the additional interest expense related to the TRA of €13.8 million as well as the accelerated amortization of €26.9 million capitalized transaction costs. This is the result of a $450.0 million early repayment on the USD TLB facility from the IPO proceeds and early full repayment and refinancing of the EUR TLB facility, USD TLB facility, and ABL facility on August 2, 2024. The accelerated amortization had to be accounted for during the three months ended June 30, 2024 since the agreement was signed in this period.
Income tax (expense) benefit
Income tax expense for the three months ended June 30, 2024 increased by €8.0 million to €36.3 million from €28.2 million for the three months ended June 30, 2023. The increase was mainly driven by an increased Profit before tax in Germany resulting in a higher current tax expense, a decrease in deferred tax assets resulting from transactions between group companies as well as tax losses for which no deferred taxes are recognized.
Income tax expense for the nine months ended June 30, 2024 increased by €25.5 million to €76.4 million from €50.9 million for the nine months ended June 30, 2023. The increase was mainly driven by an increased Profit before tax in Germany resulting in a higher current tax expense as well as tax losses for which no deferred taxes are recognized.
Net profit (loss)
Net profit for the three months ended June 30, 2024 increased by €11.5 million, or 18%, to €74.6 million from €63.1 million for the three months ended June 30, 2023. Net profit margin for the three months ended June 30, 2024 contracted by 0.1 percentage points, to 13.2% from 13.3% for the three months ended June 30, 2023. The increase of Net profit was primarily attributable to overall business growth and a decrease in General administration expenses mainly relating to non-recurring IPO expenses, as described in the section above.
Net profit for the nine months ended June 30, 2024 increased by €35.8 million, or 35%, to €139.1 million from €103.3 million for the nine months ended June 30, 2023. Net profit margin for the nine months ended June 30, 2024 expanded by 1.1 percentage points, to 10.3% from 9.2% for the nine months ended June 30, 2023. The increase of Net profit was primarily attributable overall business growth and a decrease in foreign exchange loss and other non-recurring expenses mainly relating to the IPO.
Adjusted EBITDA and Adjusted EBITDA margin for the Group
|
|
Three months ended June 30, |
|
Nine months ended June 30, |
||||||||||||
(In thousands of Euros) |
|
2024 |
|
2023 |
|
Change |
|
% Change |
|
2024 |
|
2023 |
|
Change |
|
% Change |
Adjusted EBITDA |
|
186,329 |
|
162,636 |
|
23,693 |
|
15% |
|
429,982 |
|
387,017 |
|
42,965 |
|
11% |
Adjusted EBITDA margin |
|
33.0% |
|
34.4% |
|
(1.4) |
pp |
|
|
31.9% |
|
34.6% |
|
(2.7) |
pp |
|
Adjusted EBITDA for the three months ended June 30, 2024 increased by €23.7 million, or 15%, to €186.3 million from €162.6 million for the three months ended June 30, 2023, primarily due to revenue growth of 19%. Adjusted EBITDA margin for the three months ended June 30, 2024 contracted 1.4 percentage points to 33.0% from 34.4% for the three months ended June 30, 2023, primarily due to the decline in gross profit margin outlined above which was partially offset by a favorable development of Selling and distribution expenses in relation to revenue.
Adjusted EBITDA for the nine months ended June 30, 2024 increased by €43.0 million, or 11%, to €430.0 million from €387.0 million for the nine months ended June 30, 2023, primarily due to revenue growth of 21%. Adjusted EBITDA margin for the nine months ended June 30, 2024 contracted 2.7 percentage points to 31.9% from 34.6% for the nine months ended June 30, 2023, primarily due to the decline in gross profit margin.
29
Adjusted net profit and Adjusted net profit margin for the Group
|
|
Three months ended June 30, |
|
Nine months ended June 30, |
||||||||||||
(In thousands of Euros) |
|
2024 |
|
2023 |
|
Change |
|
% Change |
|
2024 |
|
2023 |
|
Change |
|
% Change |
Adjusted net profit (loss) |
|
91,870 |
|
80,421 |
|
11,449 |
|
14% |
|
185,603 |
|
182,018 |
|
3,585 |
|
2% |
Adjusted net profit (loss) margin |
|
16.3% |
|
17.0% |
|
(0.7) |
pp |
|
|
13.8% |
|
16.3% |
|
(2.5) |
pp |
|
Adjusted net profit for the three months ended June 30, 2024 increased by €11.4 million, or 14%, to €91.9 million from €80.4 million for the three months ended June 30, 2023, primarily driven by Adjusted EBITDA growth partly offset by higher depreciation & amortization.
Adjusted net profit for the nine months ended June 30, 2024 increased by €3.6 million, or 2%, to €185.6 million from €182.0 million for the nine months ended June 30, 2023, primarily driven by Adjusted EBITDA growth partly offset by higher depreciation & amortization.
Revenue by segment
|
|
Three months ended June 30, |
|
Nine months ended June 30, |
||||||||||||
(In thousands of Euros) |
|
2024 |
|
2023 |
|
Change |
|
% Change |
|
2024 |
|
2023 |
|
Change |
|
% Change |
Americas |
|
282,865 |
|
244,101 |
|
38,764 |
|
16% |
|
718,364 |
|
617,452 |
|
100,912 |
|
16% |
Europe |
|
217,405 |
|
181,274 |
|
36,131 |
|
20% |
|
473,081 |
|
386,044 |
|
87,037 |
|
23% |
APMA |
|
63,687 |
|
46,721 |
|
16,966 |
|
36% |
|
153,874 |
|
110,042 |
|
43,832 |
|
40% |
Total reportable segment revenue |
|
563,957 |
|
472,096 |
|
91,861 |
|
19% |
|
1,345,319 |
|
1,113,538 |
|
231,781 |
|
21% |
Corporate/Other |
|
801 |
|
1,099 |
|
(298) |
|
(27)% |
|
3,607 |
|
3,830 |
|
(223) |
|
(6)% |
Group revenue |
|
564,758 |
|
473,195 |
|
91,563 |
|
19% |
|
1,348,926 |
|
1,117,368 |
|
231,558 |
|
21% |
Revenue for the Americas segment for the three months ended June 30, 2024 increased by €38.8 million, or 16%, to €282.9 million from €244.1 million for the three months ended June 30, 2023, and Revenue for the nine months ended June 30, 2024 increased by €100.9 million, or 16%, to €718.4 million from €617.5 million for the nine months ended June 30, 2023 driven by strong revenue growth in both B2B and DTC.
Revenue for the Europe segment for the three months ended June 30, 2024 increased by €36.1 million, or 20%, to €217.4 million from €181.3 million for the three months ended June 30, 2023, and Revenue for the nine months ended June 30, 2024 increased by €87.0 million, or 23%, to €473.1 million from €386.0 million for the nine months ended June 30, 2023, driven by strong revenue growth in both B2B and DTC.
Revenue for the APMA segment for the three months ended June 30, 2024 increased by €17.0 million, or 36%, to €63.7 million from €46.7 million for the three months ended June 30, 2023, and Revenue for the APMA segment for the nine months ended June 30, 2024 increased by €43.8 million, or 40%, to €153.9 million from €110.0 million for the nine months ended June 30, 2023, driven by above group-level growth in both the B2B and DTC channel. The DTC penetration increased significantly due to retail store expansion and an increase of the digital footprint in the region.
Revenue for Corporate/Other for the three months ended June 30, 2024 decreased by €0.3 million, or 27%, to €0.8 million from €1.1 million for the three months ended June 30, 2023. Revenue for Corporate/Other for the nine months ended June 30, 2024 increased by €0.2 million, or 6%, to €3.6 million from €3.8 million for the nine months ended June 30, 2023. The developments in Other revenue were primarily attributable to sales of leather material to our supplier for footbed cuttings, as well as sales of recyclable scrap materials from the production process.
30
Adjusted EBITDA and Adjusted EBITDA margin by segment
|
|
Three months ended June 30, |
|
Nine months ended June 30, |
||||||||||||
(In thousands of Euros) |
|
2024 |
|
2023 |
|
Change |
|
% Change |
|
2024 |
|
2023 |
|
Change |
|
% Change |
Americas |
|
89,922 |
|
88,283 |
|
1,639 |
|
2% |
|
234,573 |
|
242,118 |
|
(7,545) |
|
(3)% |
|
|
31.8% |
|
36.2% |
|
(4.4) |
pp |
|
|
32.7% |
|
39.2% |
|
(6.5) |
pp |
|
Europe |
|
84,220 |
|
65,643 |
|
18,577 |
|
28% |
|
165,322 |
|
120,695 |
|
44,627 |
|
37% |
|
|
38.7% |
|
36.2% |
|
2.5 |
pp |
|
|
34.9% |
|
31.3% |
|
3.6 |
pp |
|
APMA |
|
22,139 |
|
15,346 |
|
6,793 |
|
44% |
|
49,043 |
|
33,678 |
|
15,365 |
|
46% |
|
|
34.8% |
|
32.8% |
|
2.0 |
pp |
|
|
31.9% |
|
30.6% |
|
1.3 |
pp |
|
Reportable segment Adjusted EBITDA |
|
196,281 |
|
169,272 |
|
27,009 |
|
16% |
|
448,938 |
|
396,491 |
|
52,447 |
|
13% |
|
|
34.8% |
|
35.9% |
|
(1.1) |
pp |
|
|
33.4% |
|
35.6% |
|
(2.2) |
pp |
|
Corporate/Other |
|
(9,952) |
|
(6,636) |
|
(3,316) |
|
50% |
|
(18,956) |
|
(9,474) |
|
(9,482) |
|
100% |
|
|
(1,242)% |
|
(604)% |
|
(638.6) |
pp |
|
|
(526)% |
|
(247)% |
|
(278.1) |
pp |
|
Group Adjusted EBITDA |
|
186,329 |
|
162,636 |
|
23,693 |
|
15% |
|
429,982 |
|
387,017 |
|
42,965 |
|
11% |
Adjusted EBITDA margin |
|
33.0% |
|
34.4% |
|
(1.4) |
pp |
|
|
31.9% |
|
34.6% |
|
(2.7) |
pp |
|
Americas adjusted EBITDA for the three months ended June 30, 2024 increased by €1.6 million, or 2%, to €89.9 million from €88.3 million for the three months ended June 30, 2023. The increase was driven by revenue growth of 16% in the three months ended June 30, 2024 which more than offset the increase in operating expenses of 11% for the three months ended June 30, 2024. Americas adjusted EBITDA margin contracted by 4.4 percentage points to 31.8% for the three months ended June 30, 2024 from 36.2% for the three months ended June 30, 2023. Americas adjusted EBITDA for the nine months ended June 30, 2024 decreased by €7.5 million, or 3%, to €234.6 million from €242.1 million for the nine months ended June 30, 2023, primarily due to the negative impact from currency translation driven by the more pronounced depreciation of the USD relative to the Euro. The contraction was also driven by an increase in operating expenses of 18% for the nine months ended June 30, 2024, driven mainly by higher marketing expenses as well as logistics expenses. The negative effects were partially offset by revenue growth of 16% in the nine months ended June 30, 2024. Americas adjusted EBITDA margin contracted by 6.5 percentage points to 32.7% for the nine months ended June 30, 2024 from 39.2% for the nine months ended June 30, 2023.
Europe adjusted EBITDA for the three months ended June 30, 2024 increased by €18.6 million, or 28%, to €84.2 million from €65.6 million for the three months ended June 30, 2023, primarily due to revenue growth of 20%. Similarly, Europe adjusted EBITDA for the nine months ended June 30, 2024 increased by €44.6 million, or 37%, to €165.3 million from €120.7 million for the nine months ended June 30, 2023, primarily due to revenue growth of 23%. Europe adjusted EBITDA margin expanded by 2.5 percentage points from 36.2% for the three months ended June 30, 2023 to 38.7% for the three months ended June 30, 2024 and Europe adjusted EBITDA margin expanded by 3.6 percentage points from 31.3% for the nine months ended June 30, 2023 to 34.9% for the nine months ended June 30, 2024 mainly driven by revenue growing faster than Selling and distribution expenses .
APMA adjusted EBITDA for the three months ended June 30, 2024 increased by €6.8 million, or 44%, to €22.1 million from €15.3 million for the three months ended June 30, 2023, which was primarily driven by revenue growth of 36%. APMA adjusted EBITDA margin expanded by 2.0 percentage points from 32.8% for the three months ended June 30, 2023 to 34.8% for the three months ended June 30, 2024 due to operating expense growth being less pronounced than revenue growth. APMA adjusted EBITDA for the nine months ended June 30, 2024 increased by €15.4 million, or 46%, to €49.0 million from €33.7 million for the nine months ended June 30, 2023, which was primarily driven by revenue growth of 40%. APMA adjusted EBITDA margin expanded by 1.3 percentage points from 30.6% for the nine months ended June 30, 2023 to 31.9% for the nine months ended June 30, 2024.
Corporate/Other adjusted EBITDA for the three months ended June 30, 2024 decreased by €3.3 million to €(10.0) million from €(6.6) million for the three months ended June 30, 2023, driven by an increase in the expense base mainly due to increased General administration expenses, partially offset by a decrease in Selling and distribution and Other expenses. Corporate/Other adjusted EBITDA for the nine months ended June 30, 2024 decreased by €9.5 million to €(19.0) million from €(9.5) million for the nine months ended June 30, 2023.
For reconciliations to the most directly comparable IFRS measure, see section above titled “—Non-IFRS Financial Measures.”
31
B. LIQUIDITY AND CAPITAL RESOURCES
Our primary liquidity requirements are to service our debt, to fund our operations and to fund other general corporate purposes. Our ability to generate cash from our operations depends on our future operating performance, which is dependent, to some extent, on general economic, financial, competitive, market, legislative, regulatory and other factors, many of which are beyond our control, as well as other factors including those discussed in this section and the section titled “Item 3. Key Information—D. Risk Factors” in our Annual Report. We expect to finance our operations and working capital needs for the next 12 months from cash generated through operations.
Cash Flows
The following table summarizes the Company’s consolidated statement of cash flows for the three months ended June 30, 2024 and 2023, and for the nine months ended June 30, 2024 and 2023.
|
|
Three months ended June 30, |
|
Nine months ended June 30, |
||||
(in thousands of Euros) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Total cash provided by (used in): |
|
|
|
|
|
|
|
|
Operating activities |
|
281,482 |
|
236,893 |
|
286,093 |
|
240,973 |
Investing activities |
|
(17,063) |
|
(29,512) |
|
(43,395) |
|
(79,981) |
Financing activities |
|
(35,822) |
|
(88,754) |
|
(181,923) |
|
(167,258) |
Increase (decrease) in cash and cash equivalents |
|
228,596 |
|
118,628 |
|
60,775 |
|
(6,266) |
Effects of foreign currency exchange rate changes on cash and cash equivalents |
|
23 |
|
(681) |
|
(836) |
|
(11,203) |
Cash flows provided (used in) by operating activities
Cash flows provided by operating activities for the three months ended June 30, 2024 were €281.5 million compared to €236.9 million for the three months ended June 30, 2023, driven by net profit of €74.6 million and adjustments to net profit of €110.4 million as well as cash inflows from working capital of €96.5 million. Adjustments to net profit included finance costs, net of €44.6 million, depreciation and amortization of €24.8 million, income tax expense of €36.3 million, and net exchange differences of €4.2 million. Cash inflows for working capital were largely driven by inventories of €36.0 million, trade and other payables of €24.2 million, and trade and other receivables of €11.2 million.
Cash flows provided by operating activities for the three months ended June 30, 2023 were €236.9 million, driven by net profit of €63.1 million and adjustments to net profit of €90.4 million as well as cash inflows from working capital of €83.4 million. Adjustments to net profit included depreciation and amortization of €21.2 million, finance costs, net of €26.7 million, income tax expense of €28.2 million, non-cash operating items of €14.8 million, net exchange differences of €3.1 million, and offset by income tax paid of €3.7 million. Cash inflows from working capital were largely driven by inventories of €20.2 million, trade and other payables of €32.7 million, and trade and other receivables of €19.5 million.
Cash flows provided by operating activities for the nine months ended June 30, 2024 were €286.1 million, driven by net profit of €139.1 million and adjustments to net profit of €259.2 million, partially offset by cash outflows for working capital of €112.2 million. Adjustments to net profit included depreciation and amortization of €72.2 million, finance costs, net of €108.0 million, income tax expense of €76.4 million, and net exchange differences of €21.3 million, partially offset by MIP personal income tax paid of €11.4 million and income tax payments of €8.8 million. Cash outflows for working capital were largely driven by trade and other receivables of €97.9 million, inventories of €29.9 million, partially offset by a cash inflow of trade and other payables of €24.2 million.
Cash flows provided by operating activities for the nine months ended June 30, 2023 were €241.0 million, driven by net profit of €103.3 million and adjustments to net profit of €261.9 million, partially offset by cash outflows for working capital of €124.2 million. Adjustments to net profit included depreciation and amortization of €61.8 million, finance costs, net of €81.4 million, income tax expense of €50.9 million, net exchange differences of €51.4 million, and non-cash operating items of €18.1 million. Cash outflows for working capital were largely driven by trade and other receivables of €91.9 million and inventories of €68.9 million, partially offset by trade and other payables of €29.1 million.
32
Cash flows used in investing activities
Cash flows used in investing activities for the three months ended June 30, 2024 were €17.1 million compared to €29.5 million for the three months ended June 30, 2023. The decrease in cash flows used in investing activities of €12.4 million was primarily due to a decrease in purchases of property, plant and equipment of €13.3 million, to €14.6 million.
Cash flows used in investing activities for the nine months ended June 30, 2024 were €43.4 million compared to €80.0 million for the nine months ended June 30, 2023. The decrease in cash flows used in investing activities of €36.6 million was primarily due to a decrease in purchases of property, plant and equipment of €28.6 million, to €49.5 million as well as the receipt of asset-related government grants of €8.7 million in relation to the construction of our new factory in Pasewalk, Germany.
Cash flows used in financing activities
Cash flows used in financing activities for the three months ended June 30, 2024 were €35.8 million compared to €88.8 million for the three months ended June 30, 2023. The decrease in cash flows used in financing activities was mainly driven by a lower repayment of loans and borrowings of €46.3 million as well as a reduction of interest payments of €7.5 million.
Cash flows used in financing activities for the nine months ended June 30, 2024 were €181.9 million compared to €167.3 million for the nine months ended June 30, 2023. The increase in cash flows used in financing activities was mainly driven by increased repayments of loans and borrowings of €526.0 million which was largely offset by the IPO proceeds, net of transaction costs of €449.2 million.
Indebtedness
The following table sets forth the amounts owed under the Company’s debt instruments as of June 30, 2024 and September 30, 2023.
|
|
|
|
|
|
June 30, |
|
|
September 30, |
|
||
(in thousands of Euros) |
|
Currency |
|
Repayment |
|
2024 |
|
|
2023 |
|
||
Term Loan (EUR) |
|
EUR |
|
2028 |
|
|
375,000 |
|
|
|
375,000 |
|
Term Loan (USD) |
|
USD |
|
2028 |
|
|
307,181 |
|
|
|
737,506 |
|
Vendor Loan |
|
EUR |
|
2029 |
|
|
208,305 |
|
|
|
299,560 |
|
Notes |
|
EUR |
|
2029 |
|
|
428,500 |
|
|
|
428,500 |
|
Interest Payable |
|
|
|
|
|
|
14,079 |
|
|
|
29,995 |
|
Senior Note Embedded Derivative |
|
|
|
|
|
|
28,638 |
|
|
|
28,638 |
|
Amortization under the effective interest method |
|
|
|
|
|
|
(19,342 |
) |
|
|
(46,163 |
) |
Loans and borrowings |
|
|
|
|
|
|
1,342,361 |
|
|
|
1,853,036 |
|
There were two early repayments of our debt instruments in the nine months ended June 30, 2024. On October 16, 2023, we made an early partial repayment of €100.0 million on our Vendor Loan. On November 2, 2023, we made an early partial repayment of $450.0 million on our USD TLB Facility.
For further information on the Company's debt instruments see "Item 5. Operating and Financial Review and Prospects — B. Liquidity and Capital Resources" in our Annual Report.
Off-Balance Sheet Arrangements
As of the balance sheet dates of March 31, 2024 and September 30, 2023 we did not engage in any off-balance sheet arrangements, as defined in the rules and regulations of the SEC.
C. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are exposed to certain market risks arising from transactions in the normal course of our business. Such risk is principally associated with foreign currency risk, interest rate risk and credit risk. For further discussion and a sensitivity analysis of these risks, see Note 7 - Financial Risk Management objectives and policies to our 2023 audited consolidated financial statements included in our Annual Report.
33
D. CRITICAL ACCOUNTING ESTIMATES
Refer to Note 3 — Significant accounting policies and Note 4 — Significant accounting estimates, assumptions and judgments to our unaudited interim condensed consolidated financial statements in Item 1 of this Report for a discussion of accounting pronouncements recently adopted and recently issued accounting pronouncements not yet adopted and their potential impact to our financial statements.
E. RECENT ACCOUNTING PRONOUNCEMENTS
Refer to Note 3 — Significant accounting policies to our unaudited interim condensed consolidated financial statements in Item 1 of this Report for a discussion of accounting pronouncements recently adopted and recently issued accounting pronouncements not yet adopted and their potential impact to our financial statements.
F. CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”), Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”), and as defined in the Private Securities Litigation Reform Act of 1995 (“PSLRA”) that are subject to risks and uncertainties. Many of the forward-looking statements contained in this Report can be identified by the use of forward-looking words such as “anticipate,” “believe,” “could,” “expect,” “should,” “plan,” “intend,” “estimate” and “potential,” among others. Forward-looking statements provide our current expectations, intentions or forecasts of future events. Forward-looking statements include statements about expectations, beliefs, plans, objectives, intentions, assumptions and other statements that are not statements of historical fact. Words or phrases such as “aim,” “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “guidance,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “target,” “will,” “would” or similar words or phrases, or the negatives of those words or phrases, may identify forward-looking statements, but the absence of these words does not necessarily mean that a statement is not forward-looking.
Forward-looking statements are subject to known and unknown risks, uncertainties and other factors and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Our actual results could differ materially from those expected in our forward-looking statements for many reasons, including the factors described in “Item 3. Key Information—D. Risk Factors” in our Annual Report. In addition, even if our actual results are consistent with the forward-looking statements contained in this Report, those results or developments may not be indicative of results or developments in subsequent periods.
For example, factors that could cause our actual results to vary from projected future results include, but are not limited to:
34
Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events.
35
PART II OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
We are subject to litigation from time to time in the ordinary course of business. We are not currently involved in any legal proceedings that, either individually or in the aggregate, are expected to have a material adverse effect on our business or financial position. See “Item 3. Key Information—D. Risk Factors—Risks Related to Legal, Regulatory and Taxation Matters—We are subject to the risk of litigation and other claims” in our Annual Report.
ITEM 1A. RISK FACTORS
There have been no material changes to the risk factors described in the section titled "Item 3. Key Information—D. Risk Factors" in our Annual Report.
ITEM 2. INCORPORATION BY REFERENCE
The information contained in this Report is incorporated by reference into the Company’s registration statement on Form S-8 (File No. 333-274968) filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.
36
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
Birkenstock Holding plc |
|
|
|
|
|
|
|
|
|
Dated: August 29, 2024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Ruth Kennedy |
|
|
Name: |
Ruth Kennedy |
|
|
Title: |
Director |
37